Literature DB >> 33673566

CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention.

Kanika Vanshylla1, Kathrin Held2,3, Tabea M Eser2,3, Henning Gruell1,4, Franziska Kleipass1, Ricarda Stumpf1, Kanika Jain1, Daniela Weiland1, Jan Münch5, Berthold Grüttner6, Christof Geldmacher2,3, Florian Klein1,4,7.   

Abstract

Humanized mice are critical for HIV-1 research, but humanized mice generated from cord blood are inefficient at mucosal HIV-1 transmission. Most mucosal HIV-1 transmission studies in mice require fetal tissue-engraftment, the use of which is highly restricted or prohibited. We present a fetal tissue-independent model called CD34T+ with enhanced human leukocyte levels in the blood and improved T cell homing to the gut-associated lymphoid tissue. CD34T+ mice are highly permissive to intra-rectal HIV-1 infection and also show normal env diversification in vivo despite high viral replication. Moreover, mucosal infection in CD34T+ mice can be prevented by infusion of broadly neutralizing antibodies. CD34T+ mice can be rapidly and easily generated using only cord blood cells and do not require any complicated surgical procedures for the humanization process. Therefore, CD34T+ mice provide a novel platform for mucosal HIV-1 transmission studies as well as rapid in vivo testing of novel prevention molecules against HIV-1.

Entities:  

Keywords:  broadly neutralizing antibodies; humanized mice; mucosal HIV-1 prevention

Year:  2021        PMID: 33673566      PMCID: PMC7997265          DOI: 10.3390/vaccines9030198

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  53 in total

1.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

2.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

3.  Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.

Authors:  Yi-Jun Zhang; Theodora Hatziioannou; Trinity Zang; Douglas Braaten; Jeremy Luban; Stephen P Goff; Paul D Bieniasz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.

Authors:  Joshua A Horwitz; Ariel Halper-Stromberg; Hugo Mouquet; Alexander D Gitlin; Anna Tretiakova; Thomas R Eisenreich; Marine Malbec; Sophia Gravemann; Eva Billerbeck; Marcus Dorner; Hildegard Büning; Olivier Schwartz; Elena Knops; Rolf Kaiser; Michael S Seaman; James M Wilson; Charles M Rice; Alexander Ploss; Pamela J Bjorkman; Florian Klein; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

5.  Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations.

Authors:  Ryan M O'Connell; Alejandro B Balazs; Dinesh S Rao; Christine Kivork; Lili Yang; David Baltimore
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

6.  Humanized immune system mouse models: progress, challenges and opportunities.

Authors:  Todd M Allen; Michael A Brehm; Sandra Bridges; Stacy Ferguson; Priti Kumar; Oleg Mirochnitchenko; Karolina Palucka; Roberta Pelanda; Brigitte Sanders-Beer; Leonard D Shultz; Lishan Su; Mercy PrabhuDas
Journal:  Nat Immunol       Date:  2019-07       Impact factor: 31.250

7.  EBV renders B cells susceptible to HIV-1 in humanized mice.

Authors:  Donal McHugh; Renier Myburgh; Nicole Caduff; Michael Spohn; Yik Lim Kok; Christian W Keller; Anita Murer; Bithi Chatterjee; Julia Rühl; Christine Engelmann; Obinna Chijioke; Isaak Quast; Mohaned Shilaih; Victoria P Strouvelle; Kathrin Neumann; Thomas Menter; Stephan Dirnhofer; Janice Kp Lam; Kwai F Hui; Simon Bredl; Erika Schlaepfer; Silvia Sorce; Andrea Zbinden; Riccarda Capaul; Jan D Lünemann; Adriano Aguzzi; Alan Ks Chiang; Werner Kempf; Alexandra Trkola; Karin J Metzner; Markus G Manz; Adam Grundhoff; Roberto F Speck; Christian Münz
Journal:  Life Sci Alliance       Date:  2020-06-23

8.  Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.

Authors:  Philipp Schommers; Henning Gruell; Morgan E Abernathy; My-Kim Tran; Adam S Dingens; Harry B Gristick; Christopher O Barnes; Till Schoofs; Maike Schlotz; Kanika Vanshylla; Christoph Kreer; Daniela Weiland; Udo Holtick; Christof Scheid; Markus M Valter; Marit J van Gils; Rogier W Sanders; Jörg J Vehreschild; Oliver A Cornely; Clara Lehmann; Gerd Fätkenheuer; Michael S Seaman; Jesse D Bloom; Pamela J Bjorkman; Florian Klein
Journal:  Cell       Date:  2020-01-30       Impact factor: 41.582

9.  HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

Authors:  Ariel Halper-Stromberg; Joshua A Horwitz; Florian Klein; Henning Gruell; Johannes F Scheid; Stylianos Bournazos; Hugo Mouquet; Linda A Spatz; Ron Diskin; Alexander Abadir; Trinity Zang; Marcus Dorner; Eva Billerbeck; Rachael N Labitt; Christian Gaebler; Paola Marcovecchio; Reha-Baris Incesu; Thomas R Eisenreich; Paul D Bieniasz; Michael S Seaman; Pamela J Bjorkman; Jeffrey V Ravetch; Alexander Ploss; Michel C Nussenzweig
Journal:  Nature       Date:  2012-10-24       Impact factor: 49.962

10.  Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques.

Authors:  Galit Alter; Wen-Han Yu; Abishek Chandrashekar; Erica N Borducchi; Khader Ghneim; Ashish Sharma; Rebecca Nedellec; Katherine R McKenney; Caitlyn Linde; Thomas Broge; Todd J Suscovich; Tom Linnekin; Peter Abbink; Noe B Mercado; Joseph P Nkolola; Katherine McMahan; Esther A Bondzie; Venous Hamza; Lauren Peter; Nicole Kordana; Shant Mahrokhian; Michael S Seaman; Wenjun Li; Mark G Lewis; Douglas A Lauffenburger; Lars Hangartner; Rafick-Pierre Sekaly; Dan H Barouch
Journal:  Cell       Date:  2020-10-01       Impact factor: 41.582

View more
  1 in total

Review 1.  Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.

Authors:  Kazutaka Terahara; Ryutaro Iwabuchi; Yasuko Tsunetsugu-Yokota
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.